Suppr超能文献

微小 RNA let-7c 通过调节前列腺癌细胞中的 Myc 表达来抑制雄激素受体的表达和活性。

MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.

机构信息

Department of Urology, University of California at Davis, Sacramento, California 95817, USA.

出版信息

J Biol Chem. 2012 Jan 6;287(2):1527-37. doi: 10.1074/jbc.M111.278705. Epub 2011 Nov 28.

Abstract

Castration-resistant prostate cancer continues to rely on androgen receptor (AR) expression. AR plays a central role in the development of prostate cancer and progression to castration resistance during and after androgen deprivation therapy. Here, we identified miR-let-7c as a key regulator of expression of AR. miR-let-7c suppresses AR expression and activity in human prostate cancer cells by targeting its transcription via c-Myc. Suppression of AR by let-7c leads to decreased cell proliferation of human prostate cancer cells. Down-regulation of Let-7c in prostate cancer specimens is inversely correlated with AR expression, whereas the expression of Lin28 (a repressor of let-7) is correlated positively with AR expression. Our study demonstrates that the miRNA let-7c plays an important role in the regulation of androgen signaling in prostate cancer by down-regulating AR expression. These results suggest that reconstitution of miR-let-7c may aid in targeting enhanced and hypersensitive AR in advanced prostate cancer.

摘要

去势抵抗性前列腺癌仍然依赖于雄激素受体 (AR) 的表达。AR 在前列腺癌的发生和去势治疗后的进展中发挥着核心作用。在这里,我们确定了 miR-let-7c 是 AR 表达的关键调节因子。miR-let-7c 通过靶向其转录物 c-Myc 来抑制人前列腺癌细胞中 AR 的表达和活性。Let-7c 对 AR 的抑制作用导致人前列腺癌细胞增殖减少。前列腺癌标本中 Let-7c 的下调与 AR 表达呈负相关,而 Lin28(let-7 的抑制物)的表达与 AR 表达呈正相关。我们的研究表明,miRNA let-7c 通过下调 AR 表达在前列腺癌中调节雄激素信号转导方面发挥着重要作用。这些结果表明,miR-let-7c 的再构成可能有助于靶向晚期前列腺癌中增强和超敏的 AR。

相似文献

1
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
J Biol Chem. 2012 Jan 6;287(2):1527-37. doi: 10.1074/jbc.M111.278705. Epub 2011 Nov 28.
2
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
PLoS One. 2012;7(3):e32832. doi: 10.1371/journal.pone.0032832. Epub 2012 Mar 30.
5
9
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
Oncogene. 2020 Aug;39(34):5663-5674. doi: 10.1038/s41388-020-01389-7. Epub 2020 Jul 17.

引用本文的文献

3
miRNAs Dysregulated in Human Papillomavirus-Associated Benign Prostatic Lesions and Prostate Cancer.
Cancers (Basel). 2024 Dec 25;17(1):26. doi: 10.3390/cancers17010026.
4
Prostatic androgen receptor signaling shows an age-related and lobe-specific alteration in mice.
Sci Rep. 2024 Dec 5;14(1):30302. doi: 10.1038/s41598-024-79879-x.
5
Role of non-coding RNA in lineage plasticity of prostate cancer.
Cancer Gene Ther. 2025 Jan;32(1):1-10. doi: 10.1038/s41417-024-00834-z. Epub 2024 Nov 4.
6
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.
Oncogene. 2024 Jun;43(27):2092-2103. doi: 10.1038/s41388-024-03064-7. Epub 2024 May 20.
7
Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent.
Mol Ther Nucleic Acids. 2024 Apr 23;35(2):102193. doi: 10.1016/j.omtn.2024.102193. eCollection 2024 Jun 11.
8
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!
Biomedicines. 2023 Aug 18;11(8):2300. doi: 10.3390/biomedicines11082300.
9
MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer.
Transl Oncol. 2023 Feb;28:101613. doi: 10.1016/j.tranon.2022.101613. Epub 2023 Jan 4.
10
Lin28 Regulates Cancer Cell Stemness for Tumour Progression.
Cancers (Basel). 2022 Sep 24;14(19):4640. doi: 10.3390/cancers14194640.

本文引用的文献

1
Androgen regulation of gene expression.
Adv Cancer Res. 2010;107:137-62. doi: 10.1016/S0065-230X(10)07005-3.
2
Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.
Cancer Res. 2010 Apr 15;70(8):3309-19. doi: 10.1158/0008-5472.CAN-09-3703. Epub 2010 Apr 13.
3
Lin28: A microRNA regulator with a macro role.
Cell. 2010 Feb 19;140(4):445-9. doi: 10.1016/j.cell.2010.02.007.
4
Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.
Cell Tissue Res. 2010 Feb;339(2):337-47. doi: 10.1007/s00441-009-0902-y. Epub 2009 Dec 11.
5
An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.
Cell. 2009 Nov 13;139(4):693-706. doi: 10.1016/j.cell.2009.10.014. Epub 2009 Oct 29.
7
The role of let-7 in cell differentiation and cancer.
Endocr Relat Cancer. 2010 Jan 29;17(1):F19-36. doi: 10.1677/ERC-09-0184. Print 2010 Mar.
8
MicroRNAs and prostate cancer.
Endocr Relat Cancer. 2010 Jan 29;17(1):F1-17. doi: 10.1677/ERC-09-0172. Print 2010 Mar.
9
From pathogenesis to prevention of castration resistant prostate cancer.
Prostate. 2010 Jan 1;70(1):100-12. doi: 10.1002/pros.21042.
10
Towards the definition of prostate cancer-related microRNAs: where are we now?
Trends Mol Med. 2009 Sep;15(9):381-90. doi: 10.1016/j.molmed.2009.07.004. Epub 2009 Aug 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验